Literature DB >> 2263645

Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.

L Orci1, M Ravazzola, D Baetens, L Inman, M Amherdt, R G Peterson, C B Newgard, J H Johnson, R H Unger.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is attributed to a failure of pancreatic beta cells to maintain insulin secretion at a level sufficient to compensate for underlying insulin resistance. In the ZDF rat, a model of NIDDM that closely resembles the human syndrome, we have previously reported profound underexpression of GLUT-2, the high-Km facilitative glucose transporter expressed by beta cells of normal animals. Here we report that islets of diabetic rats exhibit a marked decrease in the volume of GLUT-2-positive beta cells and a reduction at the electron-microscopic level in the number of GLUT-2-immunoreactive sites per unit of beta-cell plasma membrane. The deficiency of GLUT-2 cannot be induced in normal beta cells by in vivo or in vitro exposure to high levels of glucose nor can it be prevented in beta cells of prediabetic ZDF rats by elimination of hyperglycemia. We conclude that this dearth of immunodetectable GLUT-2 in NIDDM is not secondary to hyperglycemia and therefore that it may well play a causal role in the development of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2263645      PMCID: PMC55292          DOI: 10.1073/pnas.87.24.9953

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Ultrastructural localization of intracellular antigens by the use of protein A-gold complex.

Authors:  J Roth; M Bendayan; L Orci
Journal:  J Histochem Cytochem       Date:  1978-12       Impact factor: 2.479

2.  Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study.

Authors:  E Cerasi; R Luft; S Efendic
Journal:  Diabetes       Date:  1972-04       Impact factor: 9.461

3.  Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus.

Authors:  S Srikanta; O P Ganda; G S Eisenbarth; J S Soeldner
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

Review 4.  Macro- and micro-domains in the endocrine pancreas.

Authors:  L Orci
Journal:  Diabetes       Date:  1982-06       Impact factor: 9.461

5.  Specimen preparation for electron microscopy using low temperature embedding resins.

Authors:  B L Armbruster; E Carlemalm; R Chiovetti; R M Garavito; J A Hobot; E Kellenberger; W Villiger
Journal:  J Microsc       Date:  1982-04       Impact factor: 1.758

6.  Alteration of islet cell populations in spontaneously diabetic mice.

Authors:  D Baetens; Y Stefan; M Ravazzola; F Malaisse-Lagae; D L Coleman; L Orci
Journal:  Diabetes       Date:  1978-01       Impact factor: 9.461

7.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

8.  Insulin secretion in diabetes mellitus.

Authors:  M A Pfeifer; J B Halter; D Porte
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

9.  A new genetically obese-hyperglycemic rat (Wistar fatty).

Authors:  H Ikeda; A Shino; T Matsuo; H Iwatsuka; Z Suzuoki
Journal:  Diabetes       Date:  1981-12       Impact factor: 9.461

10.  Studies on antibody production. I. A method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit.

Authors:  A H COONS; E H LEDUC; J M CONNOLLY
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

View more
  36 in total

1.  Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.

Authors:  A Ogawa; J H Johnson; M Ohneda; C T McAllister; L Inman; T Alam; R H Unger
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells.

Authors:  S D Hughes; J H Johnson; C Quaade; C B Newgard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

3.  Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats.

Authors:  M Higa; Y T Zhou; M Ravazzola; D Baetens; L Orci; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

Authors:  X Yu; S McCorkle; M Wang; Y Lee; J Li; A K Saha; R H Unger; N B Ruderman
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

5.  The role of islet secretory function in the development of diabetes in the GK Wistar rat.

Authors:  S J Hughes; K Suzuki; Y Goto
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 6.  Mechanisms of improved glucose handling after metabolic surgery: the big 6.

Authors:  Rebecca L Paszkiewicz; Richard N Bergman
Journal:  Surg Obes Relat Dis       Date:  2016-03-14       Impact factor: 4.734

7.  GLUT-2 function in glucose-unresponsive beta cells of dexamethasone-induced diabetes in rats.

Authors:  M Ohneda; J H Johnson; L R Inman; R H Unger
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  The role of reduced glucose transporter content and glucose metabolism in the immature secretory responses of fetal rat pancreatic islets.

Authors:  S J Hughes
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

9.  Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic B-cells.

Authors:  M Tiedge; S Lenzen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

10.  Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence.

Authors:  M Ohneda; L R Inman; R H Unger
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.